Dosidal · Brazil
VARILESS BIONATUS
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Brazil |
|---|---|
| Record | br:presentation:ggrem:557820030001107 (version 1) |
| Level | presentation |
| Pack code | gtin: 07896108009822 |
| Identifiers | br-ggrem: 557820030001107 br-anvisa-registration: 1200900220113 gtin: 07896108009822 |
| Source authority | ANVISA / CMED |
| Read date | 2026-11-15T05:39:41Z |
| authorisation status | category: Fitoterápico holder: 68032192000151 - BIONATUS LABORATÓRIO BOTÂNICO LTDA rows_in_register: 22 situacao: Ativo vencimento_as_published: 092027 state: current · read 2026-11-15T05:39:41Z · source: ANVISA - Dados abertos (medicamentos registrados) page |
| controlled status | state: unknown |
| identity | cnpj: 68.032.192/0001-51 company: BIONATUS LABORATÓRIO BOTÂNICO LTDA ggrem: 557820030001107 hospital_only: Não marketed_2025: Sim presentation: 170 MG COM REV CT BL AL PLAS INC X 30 product: VARILESS BIONATUS product_registration: 120090022 product_type: Fitoterápico registration: 1200900220113 substance: AESCULUS HIPPOCASTANUM L. therapeutic_class: C5C - VASOPROTETORES SISTÊMICOS state: current · read 2026-11-15T05:39:41Z · source: CMED / ANVISA - Lista de preços de medicamentos page |
| pack product code | eans: check_digit_ok: True column: EAN 1 gtin: 07896108009822 prefix: GS1 Brasil (789-790) published: 7896108009822 ggrem: 557820030001107 published_by: CMED registration: 1200900220113 state: current · read 2026-11-15T05:39:41Z · source: CMED / ANVISA - Lista de preços de medicamentos page |
| prescription class | state: unknown |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53n8uyBDET6BxHa0crnw2M1MAeQLGjo_mIgRLVvg48dPaD-EUrMco_jLaH3R_gnOBG5tIQIwB4adV8-A70yBN5rQVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/br:presentation:ggrem:557820030001107 · Same medicine in other markets · Dosidal